Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites

被引:48
|
作者
Buesen, R
Mock, M
Nau, H
Seidel, S
Jacob, J
Lampen, A
机构
[1] Hannover Sch Vet Med, Dept Food Toxicol, D-30173 Hannover, Germany
[2] Prof Dr Gernot Grimmer Fdn, Biochem Inst Environm Carcinogens, D-22927 Grosshansdorf, Germany
关键词
benzo[a]pyrene; metabolism; active transport; cytochrome P450; Caco-2; cells;
D O I
10.1016/S0009-2797(02)00076-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial cells of the gastrointestinal tract are challenged by exposure to many potentially toxic agents including the well-known food contaminant benzo[a]pyrene (B[a]P). They are equipped with a variety of Phase 1- and Phase 2-enzymes that are able to metabolize B[a]P. Furthermore, transmembranous ABC-transport proteins are expressed at the apical pole of these cells. The aim of this study was to investigate whether [C-14]B[a]P or products of the metabolism are transported by intestinal cells back into the gut lumen. The intestinal Caco-2 cell line was used as a metabolism and transport model. Experiments with Caco-2 monolayers in the Transwell(TM)-system revealed that radiolabeled substance is transported towards the apical (luminal) region. This transport was characterized as active and increased after induction of cytochromes P450 1A1 and 1B1 by beta-naphthoflavone. On the other hand, transport was decreased with the concomitant inhibition of Phase 1-metabolism. TLC-analysis revealed that the primary metabolites of B[a]P found in the supernatant were very polar; other metabolites of less polarity could only be detected in trace amounts. These results indicate that B[a]P is metabolized by Caco-2 cells to highly polar metabolites resulting from biphasic metabolism and that these polar metabolites are subject to an apically directed transport. Chemical inhibition studies showed that P-glycoprotein and MRP1 or 2 were not involved in this polarized B[a]P-metabolite secretion. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 221
页数:21
相关论文
共 50 条
  • [1] Biotransformation of benzo[a] pyrene and dibenzo[a,l] pyrene and transport of their metabolites in Caco-2 cells
    John, A.
    Hessel, S.
    Lampen, A.
    Seidel, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S38 - S38
  • [2] Detoxification of the ultimate carcinogen of benzo[a]pyrene in human Caco-2 cells
    Hessel, Stefanie
    John, Andrea
    Seidel, Albrecht
    Lampen, Alfonso
    TOXICOLOGY LETTERS, 2012, 211 : S139 - S139
  • [3] Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells
    Yamamoto, W
    Verweij, J
    de Bruijn, P
    de Jonge, MJA
    Takano, H
    Nishiyama, M
    Kurihara, M
    Sparreboom, A
    ANTI-CANCER DRUGS, 2001, 12 (05) : 419 - 432
  • [4] Transport of ginsenosides in human intestinal Caco-2 cells
    Li, WK
    Li, YM
    Fitzloff, JF
    van Breemen, RB
    DRUG METABOLISM REVIEWS, 2003, 35 : 157 - 157
  • [5] Transport of parthenolide across human intestinal cells (Caco-2)
    Khan, SI
    Abourashed, EA
    Khan, IA
    Walker, LA
    PLANTA MEDICA, 2003, 69 (11) : 1009 - 1012
  • [6] Taxol transport by human intestinal epithelial Caco-2 cells
    Walle, UK
    Walle, T
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (04) : 343 - 346
  • [7] Resveratrol transport and metabolism by human intestinal Caco-2 cells
    Kaldas, MI
    Walle, UK
    Walle, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (03) : 307 - 312
  • [8] Transport and Metabolism of Equol by Caco-2 Human Intestinal Cells
    Walsh, Kelly R.
    Failla, Mark L.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2009, 57 (18) : 8297 - 8302
  • [9] Acrylamide transport in intestinal cells (Caco-2)
    Zödl, B
    Ekmekcioglu, C
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 253 - 254
  • [10] Effects of quercetin on the detoxification of the food contaminant benzo[a]pyrene in the human intestinal caco-2 cell model
    Hessel, S.
    John, A.
    Glatt, H.
    Seidel, A.
    Lampen, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 61 - 62